Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
QuintilesIMS
Cipla
Julphar
Mallinckrodt
Johnson and Johnson
Accenture
Federal Trade Commission
UBS

Generated: October 20, 2018

DrugPatentWatch Database Preview

Prednisolone acetate; sulfacetamide sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for prednisolone acetate; sulfacetamide sodium and what is the scope of prednisolone acetate; sulfacetamide sodium patent protection?

Prednisolone acetate; sulfacetamide sodium is the generic ingredient in ten branded drugs marketed by Allergan, Alcon, Schering, Pharmafair, Novartis, Akorn, and Bausch And Lomb, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are eighty-eight drug master file entries for prednisolone acetate; sulfacetamide sodium. One supplier is listed for this compound.

Summary for prednisolone acetate; sulfacetamide sodium
US Patents:0
Tradenames:10
Applicants:7
NDAs:11
Drug Master File Entries: 88
Suppliers / Packagers: 1
DailyMed Link:prednisolone acetate; sulfacetamide sodium at DailyMed
Pharmacology for prednisolone acetate; sulfacetamide sodium

US Patents and Regulatory Information for prednisolone acetate; sulfacetamide sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon ISOPTO CETAPRED prednisolone acetate; sulfacetamide sodium SUSPENSION;OPHTHALMIC 087547-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Akorn PREDAMIDE prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 088059-001 Jul 29, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bausch And Lomb SULPHRIN prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 088089-001 Dec 28, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan BLEPHAMIDE S.O.P. prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 087748-001 Dec 3, 1986 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmafair PREDSULFAIR prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 088032-001 Apr 15, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmafair PREDSULFAIR II prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 088837-001 Dec 24, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
QuintilesIMS
Cipla
Julphar
Mallinckrodt
Johnson and Johnson
Accenture
Federal Trade Commission
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.